Premium
Tumor suppressor TA p73 gene specifically responds to deregulated E2F activity in human normal fibroblasts
Author(s) -
Ozono Eiko,
Komori Hideyuki,
Iwanaga Ritsuko,
Tanaka Tatsuya,
Sakae Takahiro,
Kitamura Hodaka,
Yamaoka Shoji,
Ohtani Kiyoshi
Publication year - 2012
Publication title -
genes to cells
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.912
H-Index - 115
eISSN - 1365-2443
pISSN - 1356-9597
DOI - 10.1111/j.1365-2443.2012.01617.x
Subject(s) - e2f , biology , suppressor , transcription factor , tumor suppressor gene , cancer research , gene , microbiology and biotechnology , cell growth , genetics , carcinogenesis
Discrimination of oncogenic growth signals from normal growth signals is crucial for tumor suppression. The transcription factor E2F, the main target of pRB , plays central role in cell proliferation by activating growth‐promoting genes. E2F also plays an important role in tumor suppression by activating growth‐suppressive genes such as pro‐apoptotic genes. The regulatory mechanism of the latter genes is not known in detail, especially in response to normal and oncogenic growth signals. E2F is physiologically activated by growth stimulation through phosphorylation of pRB . In contrast, upon dysfunction of pRB , a major oncogenic change, E2F is activated out of control by pRB , generating deregulated E2F activity. We show here that the tumor suppressor TAp73 gene, which can induce apoptosis independently of p53, responds to deregulated E2F activity, but not to physiological E2F activity induced by growth stimulation in human normal fibroblasts. We identified E2F‐responsive elements (ERE73s) in TAp73 promoter that can specifically sense deregulated E2F activity. Moreover, RB1 ‐deficient cancer cell lines harbored deregulated E2F activity that activated ERE73s and the TAp73 gene, which were suppressed by re‐introduction of pRB . These results underscore the important role of deregulated E2F in activation of the TAp73 gene, a component of major intrinsic tumor suppressor pathways.